Standard of Care in Hormone Receptor–Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools? Antiestrogen therapy remains the targeted therapy par ...
Efficacy and safety of sacituzumab govitecan in HR+/HER2– advanced breast cancer: A comprehensive systematic review and meta-analysis.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果